Thomas Jefferson University

Stephen Gollomp

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records and Publicatio - Thomas Jefferson University
Address833 Chestnut Street
Philadelphia PA 19107
Phone6106425371
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gollomp SM, Khalifian S, Gokhale S. Mitigating Immunogenicity by Coordinating Botulinum Toxin Treatments Between Aesthetics and Therapeutics. Dermatol Surg. 2024 09 01; 50(9S):S35-S37. PMID: 39196831.
      Citations:    
    2. Sattler S, Gollomp S, Curry A. A Narrative Literature Review of the Established Safety of Human Serum Albumin Use as a Stabilizer in Aesthetic Botulinum Toxin Formulations Compared to Alternatives. Toxins (Basel). 2023 10 18; 15(10). PMID: 37888650.
      Citations:    
    3. Schneider JS, Cambi F, Gollomp SM, Kuwabara H, Bra?ic JR, Leiby B, Sendek S, Wong DF. GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding. J Neurol Sci. 2015 Sep 15; 356(1-2):118-23. PMID: 26099170.
      Citations:    
    4. Truong DD, Gollomp SM, Jankovic J, LeWitt PA, Marx M, Hanschmann A, Fernandez HH. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(?)) injections in blepharospasm. J Neural Transm (Vienna). 2013 Sep; 120(9):1345-53. PMID: 23435927.
      Citations:    
    5. Schneider JS, Gollomp SM, Sendek S, Colcher A, Cambi F, Du W. A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients. J Neurol Sci. 2013 Jan 15; 324(1-2):140-8. PMID: 23199590.
      Citations:    
    6. Yang C, Garrett-Mayer E, Schneider JS, Gollomp SM, Tilley BC. Repeatable battery for assessment of neuropsychological status in early Parkinson's disease. Mov Disord. 2009 Jul 30; 24(10):1453-60. PMID: 19452561.
      Citations:    
    7. Jain V, Deshmukh A, Gollomp S. Bilateral facial paralysis: case presentation and discussion of differential diagnosis. J Gen Intern Med. 2006 Jul; 21(7):C7-10. PMID: 16808763.
      Citations:    
    8. Ondo WG, Gollomp S, Galvez-Jimenez N. A pilot study of botulinum toxin A for headache in cervical dystonia. Headache. 2005 Sep; 45(8):1073-7. PMID: 16109123.
      Citations:    
    9. Duda JE, Giasson BI, Chen Q, Gur TL, Hurtig HI, Stern MB, Gollomp SM, Ischiropoulos H, Lee VM, Trojanowski JQ. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol. 2000 Nov; 157(5):1439-45. PMID: 11073803.
      Citations:    
    10. Duda JE, Giasson BI, Gur TL, Montine TJ, Robertson D, Biaggioni I, Hurtig HI, Stern MB, Gollomp SM, Grossman M, Lee VM, Trojanowski JQ. Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol. 2000 Sep; 59(9):830-41. PMID: 11005264.
      Citations:    
    11. Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology. 2000 May 23; 54(10):1916-21. PMID: 10822429.
      Citations:    
    12. Friedman DP, Goldman HW, Flanders AE, Gollomp SM, Curran WJ. Stereotactic radiosurgical pallidotomy and thalamotomy with the gamma knife: MR imaging findings with clinical correlation--preliminary experience. Radiology. 1999 Jul; 212(1):143-50. PMID: 10405733.
      Citations:    
    13. Stern MB, Doty RL, Dotti M, Corcoran P, Crawford D, McKeown DA, Adler C, Gollomp S, Hurtig H. Olfactory function in Parkinson's disease subtypes. Neurology. 1994 Feb; 44(2):266-8. PMID: 8309571.
      Citations:    
    14. Grossman M, Carvell S, Gollomp S, Stern MB, Reivich M, Morrison D, Alavi A, Hurtig HI. Cognitive and physiological substrates of impaired sentence processing in Parkinson's disease. J Cogn Neurosci. 1993; 5(4):480-98. PMID: 23964920.
      Citations:    
    15. Grossman M, Carvell S, Stern MB, Gollomp S, Hurtig HI. Sentence comprehension in Parkinson's disease: the role of attention and memory. Brain Lang. 1992 May; 42(4):347-84. PMID: 1611464.
      Citations:    
    16. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992 Feb; 55(2):138-42. PMID: 1538221.
      Citations:    
    17. Grossman M, Carvell S, Gollomp S, Stern MB, Vernon G, Hurtig HI. Sentence comprehension and praxis deficits in Parkinson's disease. Neurology. 1991 Oct; 41(10):1620-6. PMID: 1922805.
      Citations:    
    18. Stern M, Dulaney E, Gruber SB, Golbe L, Bergen M, Hurtig H, Gollomp S, Stolley P. The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients. Arch Neurol. 1991 Sep; 48(9):903-7. PMID: 1953412.
      Citations:    
    19. Gollomp SM, Fahn S. Transient dystonia as a complication of varicella. J Neurol Neurosurg Psychiatry. 1987 Sep; 50(9):1228-9. PMID: 3668573.
      Citations:    
    20. Stern MB, Vernon GM, Gollomp SM, Hurtig HI. Low-dose, slow-increase bromocriptine in patients with progressive Parkinson's disease and complications of levodopa therapy. Bull Clin Neurosci. 1986; 51:52-6. PMID: 3455244.
      Citations:    
    21. Sadoff RL, Gollomp SM. Alerting psychiatrists to dystonia. Am J Psychiatry. 1983 Sep; 140(9):1258-9. PMID: 6614247.
      Citations:    
    22. Gollomp SM, Fahn S, Burke RE, Reches A, Ilson J. Therapeutic trials in Meige syndrome. Adv Neurol. 1983; 37:207-13. PMID: 6344589.
      Citations:    
    23. Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, Ilson J. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology. 1982 Dec; 32(12):1335-46. PMID: 6128697.
      Citations:    
    24. Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, Ilson J. Tardive dystonia and inappropriate use of neuroleptic drugs. Lancet. 1982 Jun 05; 1(8284):1299. PMID: 6123031.
      Citations:    
    25. Hakim AM, Moss G, Gollomp SM. The effect of hypoxia on the pentose phosphate pathway in brain. J Neurochem. 1976 Apr; 26(4):683-8. PMID: 965959.
      Citations:    
    Gollomp's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (152)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _